| bDMARDs | Biologic disease-modifying antirheumatic drugs |
| CASPAR | Classification Criteria for Psoriatic Arthritis |
| Clin+/US− | Clinically active but ultrasound-negative enthesitis |
| Clin−/US+ | Clinically silent but ultrasound-active enthesitis |
| Clin+/US+ | Clinically active and ultrasound-positive enthesitis |
| Clin−/US− | Clinically silent and ultrasound-negative enthesitis |
| DAPSA | Disease Activity in Psoriatic Arthritis |
| GRAPPA | Group for Research and Assessment of Psoriasis and Psoriatic Arthritis |
| IL-17i | Interleukin-17 inhibitors |
| LEI | Leeds Enthesitis Index |
| PGA | Patient global assessment |
| SJC | Swollen joint count |
| TJC | Tender joint count |
| TNFi | Tumour necrosis factor inhibitors |
| US | Ultrasound |